Skip to content
halicin

Structure via PubChem · Public domain (PubChem)

EntityQ82304130· pop 10· linked from 8 articles

Also known as SU-3327, SU 3327

Halicin (SU-3327) is an experimental drug that acts as an enzyme inhibitor of c-Jun N-terminal kinase (JNK). Originally, it was researched for the treatment of diabetes, but development was discontinued for this application due to poor results in testing. In 2019, this molecule was found by an artificial intelligence (AI) model to show antibiotic properties against a number of bacteria.

Chemical data

Formula
C5H3N5O2S3
Molecular weight
261.3 g/mol
IUPAC name
5-[(5-nitro-1,3-thiazol-2-yl)sulfanyl]-1,3,4-thiadiazol-2-amine
SMILES
C1=C(SC(=N1)SC2=NN=C(S2)N)[N+](=O)[O-]
InChIKey
NQQBNZBOOHHVQP-UHFFFAOYSA-N
XLogP
1.9
Polar surface area
192 Ų
H-bond donors
1
H-bond acceptors
9
Formal charge
0

via PubChem

Drug data · ChEMBL

Molecule type
Small molecule

via ChEMBL · EBI

Wikidata facts

Has part
carbon
Mass
260.944887336
Has use
medication
Show 5 more facts
Commons category
Halicin
chemical formula
C₅H₃N₅O₂S₃
canonical SMILES
C1=C(SC(=N1)SC2=NN=C(S2)N)[N+](=O)[O-]
Sources (3)

via Wikidata · CC0

~2 min read

Encyclopedic overview

4 sections
Contents
  • History
  • Antibiotic properties
  • References
  • External links

Halicin (SU-3327) is an experimental drug that acts as an enzyme inhibitor of c-Jun N-terminal kinase (JNK). Originally, it was researched for the treatment of diabetes, but development was discontinued for this application due to poor results in testing. In 2019, this molecule was found by an artificial intelligence (AI) model to show antibiotic properties against a number of bacteria.

==History== Halicin was previously known as SU-3327, developed by a group of researchers from Burnham Institute for Medical Research, United States in 2009 for investigations into diabetes treatment. Researchers named the molecule after the fictional artificial intelligence system Hal from 2001: A Space Odyssey.

Excerpted from Wikipedia’s “halicin” article, available under the CC BY-SA 4.0 licence.

Available in 9 languages

via Wikidata sitelinks · CC0